PROGESTERONE Drug Patent Profile
✉ Email this page to a colleague
When do Progesterone patents expire, and what generic alternatives are available?
Progesterone is a drug marketed by Amneal Pharms Ny, Bionpharma, Dr Reddys, Eugia Pharma, Sofgen Pharms, Teva Pharms, Xiromed, Accord Hlthcare, Actavis Labs Ut Inc, Am Regent, Fresenius Kabi Usa, Hikma Farmaceutica, and Lilly. and is included in fifteen NDAs.
The generic ingredient in PROGESTERONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Progesterone
A generic version of PROGESTERONE was approved as progesterone by FRESENIUS KABI USA on April 25th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROGESTERONE?
- What are the global sales for PROGESTERONE?
- What is Average Wholesale Price for PROGESTERONE?
Summary for PROGESTERONE
| US Patents: | 0 |
| Applicants: | 13 |
| NDAs: | 15 |
| Finished Product Suppliers / Packagers: | 21 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Clinical Trials: | 1,134 |
| Drug Prices: | Drug price information for PROGESTERONE |
| Drug Sales Revenues: | Drug sales revenues for PROGESTERONE |
| What excipients (inactive ingredients) are in PROGESTERONE? | PROGESTERONE excipients list |
| DailyMed Link: | PROGESTERONE at DailyMed |
See drug prices for PROGESTERONE
Recent Clinical Trials for PROGESTERONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Instituto Valenciano de Infertilidad, IVI VALENCIA | N/A |
| Ohio State University | Phase 3 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Phase 3 |
Pharmacology for PROGESTERONE
| Drug Class | Progesterone |
Medical Subject Heading (MeSH) Categories for PROGESTERONE
Anatomical Therapeutic Chemical (ATC) Classes for PROGESTERONE
US Patents and Regulatory Information for PROGESTERONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharms Ny | PROGESTERONE | progesterone | CAPSULE;ORAL | 207724-001 | Sep 7, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | PROGESTERONE | progesterone | INJECTABLE;INJECTION | 210965-001 | Dec 6, 2018 | AO | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | PROGESTERONE | progesterone | CAPSULE;ORAL | 211285-001 | Oct 26, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bionpharma | PROGESTERONE | progesterone | CAPSULE;ORAL | 200900-002 | Aug 16, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms | PROGESTERONE | progesterone | CAPSULE;ORAL | 202121-002 | Feb 29, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Farmaceutica | PROGESTERONE | progesterone | INJECTABLE;INJECTION | 091033-001 | Oct 28, 2010 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Eugia Pharma | PROGESTERONE | progesterone | CAPSULE;ORAL | 211285-002 | Oct 26, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
